Isobutyl Salicylate

Isobutyl salicylate (CAS Number 87-19-4) is an organic ester compound belonging to the salicylate family of chemicals. It is a liquid at room temperature with a characteristic fruity, wintergreen-like odor. The compound is synthesized through the esterification of salicylic acid with isobutanol. Chemically, it consists of a salicylate moiety bonded to an isobutyl group, giving it distinct organoleptic properties valued in the flavor industry.

Isobutyl salicylate is primarily used as a flavoring agent and flavor enhancer in the food and beverage industry. Its fruity, slightly spicy character makes it particularly valuable in creating complex flavor profiles for products such as candies, chewing gums, beverages, baked goods, and confectionery items. The compound is typically used in very small quantities—measured in parts per million—to achieve the desired sensory effect without dominating the overall taste profile. It is also utilized in non-food applications including cosmetics, fragrances, and personal care products, though the focus here remains on food safety and regulatory aspects.

Isobutyl salicylate has not been designated as Generally Recognized as Safe (GRAS) by the FDA. However, the absence of GRAS status does not indicate a safety concern; rather, it reflects that comprehensive GRAS affirmation petitions may not have been formally submitted or evaluated by regulatory authorities. The FDA database shows zero reported adverse events associated with isobutyl salicylate and zero product recalls attributed to this ingredient, indicating no documented safety incidents in the U.S. market.

Toxicological data on isobutyl salicylate remains limited in the published scientific literature. Like other salicylate esters, the compound is generally expected to have low acute toxicity. The primary metabolic pathway would likely involve hydrolysis to salicylic acid and isobutanol, both of which are naturally occurring compounds with established safety profiles. Salicylic acid is a common ingredient in topical skincare products and occurs naturally in many foods. However, comprehensive chronic toxicity, reproductive toxicity, and carcinogenicity studies specific to isobutyl salicylate appear not to have been published in readily accessible scientific databases.

Ingestion of salicylates can theoretically trigger reactions in individuals with salicylate sensitivity; however, the extremely low use levels of isobutyl salicylate in food products make such occurrences unlikely except in particularly sensitive populations.

In the United States, isobutyl salicylate is not on the FDA's GRAS list and does not have explicit FDA approval as a food additive. This means it cannot be legally used as a food additive in the U.S. without specific FDA authorization or an approved food additive petition. Its regulatory status in the European Union and other jurisdictions should be verified through the respective regulatory bodies, as approvals vary by region.

Manufacturers and food companies interested in using isobutyl salicylate in the U.S. market would need to petition the FDA for approval or secure GRAS affirmation through proper scientific and regulatory channels.

Published peer-reviewed studies specifically investigating the safety profile of isobutyl salicylate are limited. Most available information comes from chemical databases, safety data sheets, and broader research on salicylate compounds and ester metabolism. The chemical structure suggests it would be readily hydrolyzed in the gastrointestinal tract, similar to other salicylate esters. Research on salicylate sensitivity and dietary salicylates in general populations provides contextual information but does not directly address isobutyl salicylate specifically. Additional toxicological research would strengthen the safety database for this compound.